Use of tumor-activated hepatic stellate cell as a target for the preclinical testing of anti-angiogenic drugs against hepatic tumor development.
- Olaso, E.
- Vidal-Vanaclocha, F.
Revue:
Methods in molecular medicine
ISSN: 1543-1894
Année de publication: 2003
Volumen: 85
Pages: 79-86
Type: Révision